Titan Pharmaceuticals Stock Alpha and Beta Analysis

TTNP Stock  USD 3.63  0.04  1.11%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Titan Pharmaceuticals. It also helps investors analyze the systematic and unsystematic risks associated with investing in Titan Pharmaceuticals over a specified time horizon. Remember, high Titan Pharmaceuticals' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Titan Pharmaceuticals' market risk premium analysis include:
Beta
0.7
Alpha
0.18
Risk
5.73
Sharpe Ratio
0.0435
Expected Return
0.25
Please note that although Titan Pharmaceuticals alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Titan Pharmaceuticals did 0.18  better than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Titan Pharmaceuticals stock's relative risk over its benchmark. Titan Pharmaceuticals has a beta of 0.70  . As returns on the market increase, Titan Pharmaceuticals' returns are expected to increase less than the market. However, during the bear market, the loss of holding Titan Pharmaceuticals is expected to be smaller as well. As of 03/14/2025, Book Value Per Share is likely to drop to 9.65. In addition to that, Tangible Book Value Per Share is likely to drop to 9.65.

Enterprise Value

(695,333)

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Titan Pharmaceuticals Backtesting, Titan Pharmaceuticals Valuation, Titan Pharmaceuticals Correlation, Titan Pharmaceuticals Hype Analysis, Titan Pharmaceuticals Volatility, Titan Pharmaceuticals History and analyze Titan Pharmaceuticals Performance.
To learn how to invest in Titan Stock, please use our How to Invest in Titan Pharmaceuticals guide.

Titan Pharmaceuticals Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Titan Pharmaceuticals market risk premium is the additional return an investor will receive from holding Titan Pharmaceuticals long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Titan Pharmaceuticals. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Titan Pharmaceuticals' performance over market.
α0.18   β0.70

Titan Pharmaceuticals expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Titan Pharmaceuticals' Buy-and-hold return. Our buy-and-hold chart shows how Titan Pharmaceuticals performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Titan Pharmaceuticals Market Price Analysis

Market price analysis indicators help investors to evaluate how Titan Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Titan Pharmaceuticals shares will generate the highest return on investment. By understating and applying Titan Pharmaceuticals stock market price indicators, traders can identify Titan Pharmaceuticals position entry and exit signals to maximize returns.

Titan Pharmaceuticals Return and Market Media

The median price of Titan Pharmaceuticals for the period between Sat, Dec 14, 2024 and Fri, Mar 14, 2025 is 3.48 with a coefficient of variation of 7.39. The daily time series for the period is distributed with a sample standard deviation of 0.26, arithmetic mean of 3.54, and mean deviation of 0.21. The Stock received some media coverage during the period.
 Price Growth (%)  
       Timeline  
1
Titan Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
01/03/2025
2
Disposition of tradable shares by Chasey Peter Louis of Titan Pharmaceuticals subject to Rule 16b-3
03/03/2025
3
PHIO - Phio Pharmaceuticals Corp Latest Stock News Market Updates - StockTitan
03/10/2025

About Titan Pharmaceuticals Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Titan or other stocks. Alpha measures the amount that position in Titan Pharmaceuticals has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2024 2025 (projected)
Dividend Yield0.0017080.001518
Price To Sales Ratio38.7836.84

Titan Pharmaceuticals Upcoming Company Events

As portrayed in its financial statements, the presentation of Titan Pharmaceuticals' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Titan Pharmaceuticals' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Titan Pharmaceuticals' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Titan Pharmaceuticals. Please utilize our Beneish M Score to check the likelihood of Titan Pharmaceuticals' management manipulating its earnings.
13th of February 2024
Upcoming Quarterly Report
View
31st of December 2023
Next Fiscal Quarter End
View

Build Portfolio with Titan Pharmaceuticals

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Additional Tools for Titan Stock Analysis

When running Titan Pharmaceuticals' price analysis, check to measure Titan Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Titan Pharmaceuticals is operating at the current time. Most of Titan Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Titan Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Titan Pharmaceuticals' price. Additionally, you may evaluate how the addition of Titan Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.